T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
CareCloud
CCLD
$104M
| $92K | ﹤0.01% |
32,900
-7,900
| -19% | -$27.3K |
|
|
OLPX
2727
DELISTED
Olaplex Holdings
OLPX
| $92K | ﹤0.01% |
17,587
-8,296,853
| -100% | -$49.3M |
|
|
MRNS
2728
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $92K | ﹤0.01% |
23,100
+7,500
| +48% | +$36.9K |
|
2729
W&T Offshore
WTI
$543M
| $90K | ﹤0.01% |
16,140
+1,393
| +9% | +$9.6K |
|
|
VZIO
2730
DELISTED
VIZIO Holding Corp.
VZIO
| $90K | ﹤0.01% |
12,163
+1,664
| +16% | +$16.1K |
|
|
JNCE
2731
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $89K | ﹤0.01% |
80,336
+41,000
| +104% | +$58.4K |
|
2732
PEDEVCO
PED
$150M
| $88K | ﹤0.01% |
3,990
+1,230
| +45% | +$28.6K |
|
2733
Westwater Resources
WWR
$80.8M
| $88K | ﹤0.01% |
111,000
| – | – |
|
2734
Clarus
CLAR
$144M
| $86K | ﹤0.01% |
10,950
+450
| +4% | +$4.38K |
|
|
YMAB
2735
DELISTED
Y-mAbs Therapeutics
YMAB
| $86K | ﹤0.01% |
17,623
+915
| +5% | +$6.65K |
|
2736
Alto Ingredients
ALTO
$328M
| $85K | ﹤0.01% |
29,381
+725
| +3% | +$2.58K |
|
2737
Quantum-Si Incorporated
QSI
$191M
| $85K | ﹤0.01% |
46,351
+2,038
| +5% | +$5.25K |
|
2738
Alpha Pro Tech
APT
$55.4M
| $84K | ﹤0.01% |
20,900
+800
| +4% | +$3.26K |
|
2739
Hydrofarm Holdings
HYFM
$8.53M
| $84K | ﹤0.01% |
5,440
+2,890
| +113% | +$66K |
|
|
NUTX
2740
Nutex Health
NUTX
$1.18B
| $84K | ﹤0.01% |
+295
| New | +$56.7K |
|
2741
MaxCyte
MXCT
$151M
| $83K | ﹤0.01% |
15,174
+1,681
| +12% | +$10.3K |
|
|
ORGN
2742
DELISTED
Origin Materials
ORGN
| $83K | ﹤0.01% |
601
+52
| +9% | +$8.28K |
|
2743
Q32 Bio
QTTB
$456M
| $83K | ﹤0.01% |
3,667
| – | – |
|
2744
Curis
CRIS
$4.14M
| $81K | ﹤0.01% |
369
| – | – |
|
2745
Root
ROOT
$765M
| $81K | ﹤0.01% |
+17,995
| New | +$124K |
|
|
AMPS
2746
DELISTED
Altus Power
AMPS
| $81K | ﹤0.01% |
12,375
+1,062
| +9% | +$8.67K |
|
2747
Angi Inc
ANGI
$178M
| $80K | ﹤0.01% |
3,400
+1,410
| +71% | +$31.5K |
|
|
TUP
2748
DELISTED
Tupperware Brands Corporation
TUP
| $80K | ﹤0.01% |
19,347
-6,334
| -25% | -$34K |
|
|
BRMK
2749
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $79K | ﹤0.01% |
22,204
+1,922
| +9% | +$8.95K |
|
|
ASXC
2750
DELISTED
Asensus Surgical, Inc.
ASXC
| $78K | ﹤0.01% |
225,800
-70,300
| -24% | -$28.6K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.